Table 1.

Patients Having Hemophilic With and Without Inhibitor.

	Type	Inhibitor BU	FVIII or FIX activity, %	Treatment	APTT: Acceleration Peak 1
					Time, second	Height, mAbs/s2	Width, second
1	Hemophilia A	<0.5	2.9	On-demand	58.2	20.4	178
2	Hemophilia B	<0.5	3.6	On-demand	53.2	11.6	242
3	Hemophilia A	<0.5	<1.0	Prophylaxis treatment	89.7	51	37.5
4	Hemophilia A	<0.5	<1.0	Prophylaxis treatment	58.1	25.4	116
5	Hemophilia A	<0.5	9.3	On-demand	49.2	18.4	379
6	Hemophilia A	<0.5	<1.0	Prophylaxis treatment	25.6	6.1	656
7	Hemophilia B	<0.5	9.4	On-demand	41.4	9.8	736
8	Hemophilia A	<0.5	<1.0	Prophylaxis treatment	39.9	9.3	414
9	Hemophilia B	<0.5	<1.0	On-demand	62.7	28	161
10	Hemophilia B	<0.5	<1.0	Prophylaxis treatment	70.1	20.6	282
11	Hemophilia A	<0.5	1.3	On-demand	52.5	15.2	15.6
12	Pancreas cancer	9.2	4.1	Prednisolone	65.1	19.5	31.6
13	Hemophilia A	5.6	<1.0	Bypass therapy	125.6	24.2	14.4
14	Hemophilia A	93.2	<1.0	Bypass therapy	69	62.1	33.5
15	Hemophilia A	76.2	2.3	Bypass therapy	68.4	23.1	114
16	Hemophilia A	95.1	<1.0	Bypass therapy	114.4	113	24.5

Abbreviations: Abs, absorbance; APTT, activated partial thromboplastin time; BU, Bethesda unit; FVIII, factor VIII; FIX, factor IX.